Literature DB >> 8040939

A multicenter study of popliteal aneurysms. Joint Vascular Research Group.

Z A Varga1, J C Locke-Edmunds, R N Baird.   

Abstract

PURPOSE: The purpose of this study was to determine current practice in the treatment of all categories of popliteal aneurysms (PA) in light of the efficacy of intraarterial thrombolysis in PA presenting as acute ischemia.
METHODS: Prospective data collected from 19 vascular surgeons from 200 PA in 137 patients during a 4-year period from 1989.
RESULTS: The most common presentation (125 PA) was leg ischemia, with the most severe symptom being claudication in 58, acute limb-threatening ischemia in 56, and digital atheroembolism in 11 limbs. The nonischemic group (75 PA) included 43 symptom-free cases and 32 cases with local symptoms arising from the popliteal fossa. Of 62 patients requiring emergency treatment, bypasses were done in 56, 10 of whom had early occlusion. Thrombolysis was used alone or in combination with bypass on 23 occasions, with 16 successful outcomes. Of 138 PA presenting electively, 80 underwent bypass, with one early occlusion, and 58 were observed. In the observed group, 18 later underwent bypass during a median follow-up of 22 months. The indications for late bypass were expansion of a small (< 2 cm) asymptomatic PA and the development of distal ischemia. There were 18 deaths in the observed group because of medical unfitness; limb ischemia did not develop during follow-up.
CONCLUSIONS: Intraarterial thrombolysis is of value in restoring the distal run off before bypass in PA presenting as acute limb-threatening ischemia. However, the results do not justify an expectant policy for asymptomatic aneurysms.

Entities:  

Mesh:

Year:  1994        PMID: 8040939     DOI: 10.1016/0741-5214(94)90003-5

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  9 in total

1.  Long-term follow-up of surgically excluded popliteal artery aneurysms with multi-slice CT angiography and Doppler ultrasound.

Authors:  Sebastien Deglise; Salah D Qanadli; Elena Rizzo; Nicolas Ducrey; Francesco Doenz; Claude Haller; Alban Denys; Jean-Marc Corpataux
Journal:  Eur Radiol       Date:  2006-01-17       Impact factor: 5.315

Review 2.  [Popliteal artery aneurysm: surgical and endovascular therapy].

Authors:  R Ghotbi; K Deilmann
Journal:  Chirurg       Date:  2013-03       Impact factor: 0.955

3.  Popliteal aneurysm: diagnostic workup and results of surgical treatment.

Authors:  Yves Harder; Hanspeter Notter; Peter Nussbaumer; Alfred Leiser; Corina Canova; Markus Furrer
Journal:  World J Surg       Date:  2003-07       Impact factor: 3.352

Review 4.  Popliteal aneurysms: from John Hunter to the 21st century.

Authors:  R B Galland
Journal:  Ann R Coll Surg Engl       Date:  2007-07       Impact factor: 1.891

5.  A rare case of Streptococcus sanguinis mycotic popliteal aneurysm.

Authors:  Karan Jolly; Rachel Barratt; Amit Nair
Journal:  JMM Case Rep       Date:  2014-12-01

6.  Comparison of popliteal artery aneurysm outcomes after open repair and endovascular repair: reducing post-operative type II endoleak and sac enlargement.

Authors:  Jinting Ge; Tiehao Wang; Jichun Zhao; Ding Yuan; Bin Huang; Yi Yang
Journal:  Ann Transl Med       Date:  2021-11

7.  Bilateral giant femoropopliteal artery aneurysms: a case report.

Authors:  Theodossios P Perdikides; Efthimios Avgerinos; Efstratios Christianakis; Theofanis Fotis; Anastasios Chronopoulos; Konstantinos X Siafakas; Nikolaos Pashalidis; Dimitrios K Filippou
Journal:  J Med Case Rep       Date:  2008-04-20

Review 8. 

Authors:  Rodrigo Nóbrega Bandeira; Daniel Guimarães Cacione; Francisco Chavier Vieira Bandeira; Ariane de Sousa Pelissoni; Cibele Ohany Nogueira Leite; Luis Carlos Uta Nakano
Journal:  J Vasc Bras       Date:  2018 Jan-Mar

9.  When size does not matter: a rare case of popliteal artery aneurysm presenting with foot drop and its endovascular management.

Authors:  Jeong-Moh J Yahng; Lei Ying
Journal:  J Surg Case Rep       Date:  2019-12-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.